Research continues to advance understanding of eczema and potential treatments. New biologics and targeted therapies show promise in managing severe cases that don’t respond to traditional ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

The Hall Street shelter in Brooklyn, which drew numerous complaints, is among several that will soon close in New York. By Jeffery C. Mays Shanti Gooljar grabs some coffee before eight hours of ...

Eczema has some trademark features, but everyone’s condition is a little different. What works for one person might not work for you. You will also want to be sure that you don’t follow any advice ...

Baby boomers and users of weight loss drugs suffering from “facial sagging” are flocking to injectable aesthetic treatments ...

Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss ...

It is launching as abortion rights advocates brace for new attacks on abortion access ... and the ability for providers to prescribe the pills online. They say medication abortion is dangerous ...

Discover why Incyte's strong growth trajectory and upcoming product launches make it an attractive investment with a ...

DIVORCE are today sharing their first new music of 2025. New single 'Pill' is out now. The band's debut album 'Drive to Goldenhammer' is out March 7th via Gravity/Capitol. Released on the heels of ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Washington State’s program is the first, but other states are expected to try allowing pharmacists to prescribe the pills to counter ... in most states. The new effort is small so far ...

Eczema is now a worldwide epidemic. In the UK up to one-fifth of school-age children and one in 12 adults suffer from it. It is itchy, painful and often unsightly, reduces the quality of life and ...